As of Feb 21, 2025, BioNTech SE Intrinsic Value is $167.3. This suggests it may be undervalued by 39.4% compared to its current price of around $120.0.

What is BioNTech SE DCF (discounted cash flow) valuation?

As of Feb 21, 2025, BioNTech SE's Discounted Cash Flow (DCF) valuation estimates its share price at $232.0. This suggests it may be overvalued by 93.3% to its current price of around $120.0, using a discount rate of 7.6% and terminal growth rate of 3.0%.

Is BioNTech SE overvalued or undervalued?

BioNTech SE is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $167.3, compared to a market price of around $120.0. This suggests a potential undervaluation of 39.4%.